Active Not Recruiting OBSERVATIONAL NCT05652400

HIV Transmission in the Era of Scaling up Antiretroviral Therapy in Ethiopia (THESA)

HIV Transmission in the Era of Scaling up Access to Antiretroviral Therapy in Ethiopia

Sponsor: Armauer Hansen Research Institute, Ethiopia

Conditions Antiretroviral Therapy HIV-1-infection

Interventions Exposure to antiretroviral therapy

Updated 5 times since 2023 Last updated: Mar 14, 2025 Started: Jul 1, 2022 Primary completion: Dec 31, 2024 Completion: Jan 31, 2026

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Antiretroviral Therapy and HIV-1-infection, this trial is ongoing. The trial is conducted by Armauer Hansen Research Institute, Ethiopia and has accumulated 5 data snapshots since 2022. Infectious disease trials contribute critical data for public health response and treatment development.

Status Flow

Change History

5 versions recorded

Apr 2025 — Present [monthly]

Active Not Recruiting

Status: Recruiting → Active Not Recruiting
Sep 2024 — Apr 2025 [monthly]

Recruiting
Jul 2024 — Sep 2024 [monthly]

Recruiting
Apr 2024 — Jul 2024 [monthly]

Recruiting
Jan 2023 — Apr 2024 [monthly]

Recruiting

First recorded

Jul 2022

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Armauer Hansen Research Institute, Ethiopia
Ethiopian Public Health Institute
Lund University
Oromia Regional Health Bureau

Data source: Lund University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Ādama, Ethiopia